Clinical Trial Update: Efficacy Study of Sequential Therapy of Peginterferon Alfa-2a Following Entecavir in Patient With Chronic Hepatitis B. [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating sequential peginterferon alfa-2a after entecavir in chronic hepatitis B; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• Baraclude (entecavir)
• Pegasys (pegylated interferon alfa-2a)

Snippet

Sponsor: Hanyang University | Conditions: Hepatitis B, Chronic | Phase 3 | Status: UNKNOWN